Humana Inc. Profile Avatar - Palmy Investing

Humana Inc.

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit p…
Medical - Healthcare Plans
US, Louisville [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
100.00 100.00 85.35 85.10 84.62 84.25 86.52 86.62 87.79 86.78 88.63 86.97 87.82 86.36 87.61
Profit Margin
3.36 3.25 3.85 3.12 2.98 2.36 2.35 1.13 4.55 2.96 4.17 4.36 3.53 3.02 2.34
Operating Margin
5.52 5.48 6.36 5.15 4.99 4.87 4.82 3.20 7.93 4.03 5.35 6.06 4.11 4.27 3.77
EPS Growth
60.47 5.48 30.99 -11.89 3.31 -4.74 14.79 -51.87 312.17 -27.75 64.95 26.15 -10.52 -2.59 -9.51
Return on Assets (ROA)
7.35 6.83 8.01 6.12 5.94 4.89 5.16 2.42 9.01 6.62 9.31 9.63 6.61 6.52 5.31
Return on Equity (ROE)
18.00 15.88 17.60 13.81 13.21 11.89 12.33 5.75 24.87 16.56 22.49 24.53 18.24 18.33 15.31
Return on Invested Capital (ROIC)
14.16 12.95 14.84 10.94 10.72 9.04 9.30 4.60 17.42 11.33 15.08 16.16 10.12 11.68 10.76
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
14.50 12.91 11.10 14.69 14.48 17.72 17.90 16.95 18.62 24.55 20.26 19.96 28.91 26.53 25.22
Debt/Equity
35.54 30.02 24.37 33.18 32.24 43.12 42.73 40.28 51.42 61.41 48.94 50.85 79.73 74.61 72.72
Debt/EBITDA
22.42 19.13 22.21 69.20 74.99 79.12 60.38 19.36 21.47 137.90 45.41 43.61 228.18 132.18 164.78
Debt/Capitalization
26.22 23.09 19.60 24.91 24.38 30.13 29.94 28.71 33.96 38.05 32.86 33.71 44.36 42.73 42.10
Interest Debt per Share USD
12.90 13.01 12.54 18.83 19.96 28.22 30.83 30.08 36.70 46.97 45.75 54.94 102.15 93.54 99.45
Debt Growth
-5.04 1.25 -5.45 49.36 2.32 38.50 6.30 -2.65 17.59 23.30 -5.59 18.49 83.67 -10.89 7.40
Liquidity
Current Ratio
171.39 134.99 140.01 137.43 139.47 147.19 149.09 148.27 138.48 133.67 147.70 140.45 122.06 152.42 158.89
Quick Ratio
128.78 126.56 127.15 117.83 115.41 107.06 104.37 116.79 115.02 133.67 147.70 140.45 122.06 120.01 123.75
Cash Ratio
24.09 22.28 17.24 15.33 12.90 19.36 24.40 35.51 32.17 23.40 37.23 35.74 22.52 29.46 24.87
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
- - - - - - - - - - - - - - - - - - -211.14 -193.93 -190.52 -155.88 - - -56.47
Receivables Turnover
3,759.07 3,531.55 3,562.09 5,337.79 4,348.74 4,152.40 4,676.06 4,248.36 6,295.90 5,607.09 6,144.70 6,779.88 4,579.05 5,547.79 5,230.47
Payables Turnover
- - - - 302.58 75.92 80.23 84.79 78.36 73.77 56.32 92.35 74.08 82.69 79.10 87.37 200.76
Asset Turnover
218.75 210.32 208.00 195.84 199.24 206.68 219.75 214.12 197.83 223.95 223.18 220.64 187.32 215.70 226.99
Coverage
Interest Coverage
1,613.34 1,765.30 2,150.46 1,920.00 1,472.14 1,230.21 1,406.99 921.16 1,761.16 1,051.38 1,433.88 1,651.59 1,048.47 989.78 814.00
Asset Coverage
300 400 500 300 300 300 300 300 200 200 300 300 200 200 200
Cash Flow Coverage (CFGR)
69.26 107.87 105.80 65.52 57.14 38.90 19.63 44.98 80.04 34.82 89.70 80.79 17.64 40.15 33.67
EBITDA Coverage
1,800 2,000 2,400 2,200 1,700 1,400 1,600 1,100 1,900 1,200 1,600 1,800 1,200 1,200 900
Dividend Coverage
- - - - -1,700 -700 -700 -600 -700 -300 -1,100 -600 -900 -1,000 -800 -700 -500
Time Interest Earned (TIE)
100 100 - - - - - - - - - - - - - - - - - - - - - - - - 600
Market Prospects
Dividend Yield
- - - - 0.57 1.49 1.03 0.78 0.64 0.58 0.61 0.67 0.59 0.60 0.59 0.61 0.76
Earnings Yield
14.15 11.97 9.79 11.03 7.57 5.18 4.78 2.02 6.83 4.27 5.51 6.21 4.91 4.33 4.39
Price/Earnings (P/E)
706.53 835.41 1,021.27 906.93 1,320.67 1,930.77 2,090.85 4,963.68 1,464.23 2,340.28 1,815.07 1,610.85 2,035.23 2,307.57 2,278.31
Price/Book (P/B)
127.17 132.64 179.73 125.27 174.51 229.59 257.87 285.23 364.20 387.63 408.19 395.09 371.23 422.90 348.71
Price/Sales (P/S)
23.73 27.12 39.35 28.33 39.35 45.66 49.14 56.05 66.67 69.21 75.72 70.30 71.86 69.72 53.28
Price/Cash Flow (P/CF)
516.72 409.69 697.06 576.32 947.40 1,368.72 3,073.64 1,574.22 884.83 1,812.56 929.86 961.82 2,638.96 1,411.61 1,424.44
End of HUM's Analysis
CIK: 49071 CUSIP: 444859102 ISIN: US4448591028 LEI: - UEI: -
Secondary Listings